Cleared Traditional

K112513 - EBONY PTA 0.014 PERIPHERAL DILATATION C...

K112513 is an FDA 510(k) clearance for EBONY PTA 0.014 PERIPHERAL DILATATION C..., manufactured by Natec Medical , Ltd.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 101-day FDA review.

K112513 · Natec Medical , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
101d
Days
Class 2
Risk

K112513 is an FDA 510(k) clearance for the EBONY PTA 0.014 PERIPHERAL DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Natec Medical , Ltd. (Crofton, US). The FDA issued a Cleared decision on December 9, 2011 after a review of 101 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Natec Medical , Ltd. devices

FDA 510(k) Submission Details - K112513

510(k) Number K112513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2011
Decision Date December 09, 2011
Days to Decision 101 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 125d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 264
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K112513.
ATLAS PTA BALLOON DILATATION CATHETER
K120971 · Bard Peripheral Vascular, Inc. · Apr 2012
CONQUEST 40 PTA DILATATION CATHETER
K120660 · Bard Peripheral Vascular, Inc. · Mar 2012
GLADIATOR PTA BALLOON DILATION CATHETER
K113681 · Boston Scientific · Jan 2012
ATB ADVANCE PTA DILATATION CATHETER
K113300 · Cook, Inc. · Dec 2011
CHARGER PTA BALLON DILATATION CATHETER
K112697 · Boston Scientific · Nov 2011
ARMADA 35/35LL PTA CATHETER
K111899 · Abbott Vascular · Oct 2011